SUPN
Price:
$35.6
Market Cap:
$1.97B
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise Qelbree, a selective norepinephrine reuptake inhibitor indicated for the treatment of attention-deficit hy...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-05-01
Stock Exchange
NASDAQ
Ticker
SUPN
According to Supernus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 6.26%. This represents a change of 314.36% compared to the average of 1.51% of the last 4 quarters.
The mean historical ROE of Supernus Pharmaceuticals, Inc. over the last ten years is 18.27%. The current 6.26% ROE has changed -65.73% with respect to the historical average. Over the past ten years (40 quarters), SUPN's ROE was at its highest in in the September 2016 quarter at 35.66%. The ROE was at its lowest in in the September 2023 quarter at -1.75%.
Average
18.27%
Median
18.02%
Minimum
0.14%
Maximum
47.57%
Discovering the peaks and valleys of Supernus Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 303.47%
Maximum Annual ROE = 47.57%
Minimum Annual Increase = -110.10%
Minimum Annual ROE = 0.14%
Year | ROE | Change |
---|---|---|
2023 | 0.14% | -97.92% |
2022 | 6.85% | 4.62% |
2021 | 6.55% | -61.58% |
2020 | 17.04% | -10.24% |
2019 | 18.99% | -22.50% |
2018 | 24.50% | 14.40% |
2017 | 21.42% | -54.98% |
2016 | 47.57% | 303.47% |
2015 | 11.79% | -57.66% |
2014 | 27.85% | -110.10% |
The current ROE of Supernus Pharmaceuticals, Inc. (SUPN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.51%
5-year avg
9.91%
10-year avg
18.27%
Supernus Pharmaceuticals, Inc.’s ROE is less than Prestige Consumer Healthcare Inc. (12.35%), greater than Evotec SE (-16.30%), less than Collegium Pharmaceutical, Inc. (40.81%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Eagle Pharmaceuticals, Inc. (17.39%), greater than ANI Pharmaceuticals, Inc. (-1.60%), less than Phibro Animal Health Corporation (6.59%), greater than Pacira BioSciences, Inc. (-10.70%), less than Dr. Reddy's Laboratories Limited (18.58%), greater than Silver Spike Investment Corp. (0%), greater than Regencell Bioscience Holdings Limited (-48.12%),
Company | ROE | Market cap |
---|---|---|
12.35% | $3.89B | |
-16.30% | $1.77B | |
40.81% | $937.19M | |
-52.42% | $2.21B | |
17.39% | $6.74M | |
-1.60% | $1.14B | |
6.59% | $876.50M | |
-10.70% | $898.99M | |
18.58% | $13.05B | |
0% | $66.72M | |
-48.12% | $67.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Supernus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Supernus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Supernus Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Supernus Pharmaceuticals, Inc. (SUPN)?
What is the highest ROE for Supernus Pharmaceuticals, Inc. (SUPN)?
What is the 3-year average ROE for Supernus Pharmaceuticals, Inc. (SUPN)?
What is the 5-year average ROE for Supernus Pharmaceuticals, Inc. (SUPN)?
How does the current ROE for Supernus Pharmaceuticals, Inc. (SUPN) compare to its historical average?